Morikawa and colleagues further explored this role of p53 in energy balance and described that among non-obese patients, p53 positivity was associated with reduced cancer-specific survival while an adverse effect of obesity on CRC patient mortality was observed in p53 negative subjects [37]. The gene discussed is TP53; the disease is obesity due to melanocortin 4 receptor deficiency.